TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Buprenorphine, Naloxone Drug Combination/adverse effects
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
AU - L. A. Grande
A1 - 
AD - Olympia Bupe Clinic at Capital Recovery Center, Olympia, WA; University of Washington Department of Family Medicine, Seattle, WA; Pioneer Family Practice, Lacey, WA.
BT - Journal of addiction medicine
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1097/ADM.0000000000000837
IS - 1
JF - Journal of addiction medicine
LA - eng
M1 - Journal Article
PB - American Society of Addiction Medicine
PP - United States
PY - 2022
SN - 1935-3227; 1932-0620
SP - 4
EP - 6
EP - 
T1 - Prescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone
T2 - Journal of addiction medicine
TI - Prescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33758111
U3 - 10.1097/ADM.0000000000000837
VL - 16
VO - 1935-3227; 1932-0620
Y1 - 2022
Y2 - Jan-Feb 01
ER -